aap Implantate AG (CHIX:AAQ1D) 3-Year RORE % : -51.33% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:AAQ1D aap Implantate AG CHIX:AAQ1D
43 GF Score
Price €3.15
GF Value €1.87
! 4 Warning Signs
View Full Analysis

What is aap Implantate AG 3-Year RORE %?

aap Implantate AG CHIX:AAQ1D 43 3-Year RORE % is -51.33 as of Dec. 2025. GuruFocus rates CHIX:AAQ1D with a GF Score™ of 43/100 and a GF Value™ of €1.87. The stock has 4 warning signs investors should review. Among 775 Medical Devices & Instruments companies, aap Implantate AG ranks worse than 82.19% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. aap Implantate AG's 3-Year RORE % for the quarter that ended in Dec. 2025 was -51.33%.

The industry rank for aap Implantate AG's 3-Year RORE % or its related term are showing as below:

CHIX:AAQ1d's 3-Year RORE % is ranked worse than
82.19% of 775 companies
in the Medical Devices & Instruments industry
Industry Median: -4.03 vs CHIX:AAQ1d: -51.33

aap Implantate AG  (CHIX:AAQ1d) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


aap Implantate AG 3-Year RORE % Related Terms


aap Implantate AG 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for aap Implantate AG's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aap Implantate AG 3-Year RORE % Chart

aap Implantate AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -60.03 -60.31 21.20 -4.60 -51.33

aap Implantate AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.20 17.04 -4.60 4.20 -51.33

CHIX:AAQ1D vs ABT, SYK, MDT: 3-Year RORE % Comparison

For the Medical Devices subindustry, aap Implantate AG's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aap Implantate AG 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's 3-Year RORE % falls into.


CHIX:AAQ1D
43GF Score
aap Implantate AG CHIX:AAQ1D
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aap Implantate AG 3-Year RORE % Calculation

aap Implantate AG's 3-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.19--0.96 )/( -1.5-0 )
=0.77/-1.5
=-51.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -51.33 mean?
aap Implantate AG (CHIX:AAQ1D) has a 3-Year RORE % of -51.33 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on aap Implantate AG and its competitors. According to the industry distribution chart, aap Implantate AG ranks #637 out of 775 companies in the Medical Devices & Instruments industry, placing it in the top 82.2%.
Is aap Implantate AG's 3-Year RORE % too high?
aap Implantate AG's current 3-Year RORE % is -51.33. Based on the distribution chart, aap Implantate AG ranks #637 out of 775 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, aap Implantate AG has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, aap Implantate AG ranks #637 out of 775 companies for 3-Year RORE %. This places aap Implantate AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on aap Implantate AG and its competitors. aap Implantate AG's current 3-Year RORE % is -51.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
aap Implantate AG (CHIX:AAQ1D) has a current 3-Year RORE % of -51.33. The stock's GF Value™ is €1.87, compared to a current price of €3.15 — trading 68.2% above its estimated fair value. The current 3-Year RORE % is -51.33. aap Implantate AG's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For aap Implantate AG (CHIX:AAQ1D), the current 3-Year RORE % is -51.33 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aap Implantate AG (CHIX:AAQ1D) Overvalued in 2026?

Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued. The current stock price of €3.15 is trading 68.2% above its estimated GF Value™ of €1.87.

Key valuation signals for CHIX:AAQ1D:

  • 3-Year RORE %: -51.33
  • GF Value™: €1.87 vs. price of €3.15 (68.2% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the CHIX:AAQ1D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


aap Implantate AG Business Description

Other Exchanges 0N5A:UKAAQ1:Germany
Address Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
43GF Score

Get the complete analysis for CHIX:AAQ1D

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.15
Price
€1.87
GF Value